A detailed history of Qube Research & Technologies LTD transactions in Zoetis Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 395,130 shares of ZTS stock, worth $64.3 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
395,130
Previous 3,793 10317.35%
Holding current value
$64.3 Million
Previous $657,000 11650.38%
% of portfolio
0.12%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$172.58 - $196.48 $67.5 Million - $76.9 Million
391,337 Added 10317.35%
395,130 $77.2 Million
Q2 2024

Aug 14, 2024

SELL
$145.54 - $178.83 $301 Million - $370 Million
-2,071,267 Reduced 99.82%
3,793 $657,000
Q1 2024

May 14, 2024

BUY
$165.67 - $199.94 $273 Million - $330 Million
1,650,590 Added 388.86%
2,075,060 $351 Million
Q4 2023

Feb 13, 2024

BUY
$151.44 - $200.09 $442,204 - $584,262
2,920 Added 0.69%
424,470 $83.8 Million
Q3 2023

Nov 13, 2023

SELL
$167.14 - $192.77 $32.2 Million - $37.1 Million
-192,681 Reduced 31.37%
421,550 $73.3 Million
Q2 2023

Aug 14, 2023

BUY
$160.94 - $186.23 $46.5 Million - $53.8 Million
288,882 Added 88.79%
614,231 $106 Million
Q1 2023

May 15, 2023

BUY
$145.48 - $175.02 $27.7 Million - $33.3 Million
190,288 Added 140.89%
325,349 $54.2 Million
Q4 2022

Feb 14, 2023

SELL
$131.14 - $157.47 $6.18 Million - $7.42 Million
-47,147 Reduced 25.88%
135,061 $19.8 Million
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $21.6 Million - $26.6 Million
145,693 Added 398.99%
182,208 $27 Million
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $71.2 Million - $91.3 Million
-456,333 Reduced 92.59%
36,515 $6.28 Million
Q1 2022

May 09, 2022

BUY
$181.39 - $234.03 $89.4 Million - $115 Million
492,848 New
492,848 $92.9 Million
Q4 2021

Feb 01, 2022

SELL
$193.69 - $247.03 $8.77 Million - $11.2 Million
-45,291 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $4.1 Million - $4.55 Million
21,677 Added 91.8%
45,291 $8.79 Million
Q2 2021

Aug 13, 2021

BUY
$155.9 - $187.99 $3.68 Million - $4.44 Million
23,614 New
23,614 $4.4 Million
Q1 2021

May 14, 2021

SELL
$144.0 - $169.39 $791,136 - $930,628
-5,494 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$157.07 - $174.35 $3.26 Million - $3.61 Million
-20,729 Reduced 79.05%
5,494 $909,000
Q3 2020

Nov 12, 2020

SELL
$137.1 - $165.37 $12.6 Million - $15.2 Million
-91,787 Reduced 77.78%
26,223 $4.34 Million
Q2 2020

Aug 14, 2020

BUY
$111.92 - $142.53 $12.6 Million - $16 Million
112,399 Added 2003.19%
118,010 $16.2 Million
Q1 2020

May 15, 2020

BUY
$92.66 - $144.94 $519,915 - $813,258
5,611 New
5,611 $660,000
Q4 2019

Feb 13, 2020

SELL
$116.25 - $133.25 $577,646 - $662,119
-4,969 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$112.57 - $128.43 $559,360 - $638,168
4,969 New
4,969 $619,000
Q2 2019

Aug 02, 2019

SELL
$97.98 - $114.28 $821,268 - $957,894
-8,382 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$81.56 - $100.67 $683,635 - $843,815
8,382 New
8,382 $844,000
Q4 2018

Feb 14, 2019

SELL
$79.28 - $95.27 $511,197 - $614,300
-6,448 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$83.5 - $93.23 $319,304 - $356,511
3,824 Added 145.73%
6,448 $590,000
Q2 2018

Aug 14, 2018

BUY
$79.9 - $89.2 $209,657 - $234,060
2,624 New
2,624 $224,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $76.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.